These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17573489)

  • 1. Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction.
    Philip G; Pearlman DS; Villarán C; Legrand C; Loeys T; Langdon RB; Reiss TF
    Chest; 2007 Sep; 132(3):875-83. PubMed ID: 17573489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group.
    Edelman JM; Turpin JA; Bronsky EA; Grossman J; Kemp JP; Ghannam AF; DeLucca PT; Gormley GJ; Pearlman DS
    Ann Intern Med; 2000 Jan; 132(2):97-104. PubMed ID: 10644288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children.
    Fogel RB; Rosario N; Aristizabal G; Loeys T; Noonan G; Gaile S; Smugar SS; Polos PG
    Ann Allergy Asthma Immunol; 2010 Jun; 104(6):511-7. PubMed ID: 20568384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset and duration of attenuation of exercise-induced bronchoconstriction in children by single-dose of montelukast.
    Wasfi YS; Kemp JP; Villarán C; Massaad R; Xin W; Smugar SS; Knorr BA; Philip G
    Allergy Asthma Proc; 2011; 32(6):453-9. PubMed ID: 22221440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.
    Pearlman DS; van Adelsberg J; Philip G; Tilles SA; Busse W; Hendeles L; Loeys T; Dass SB; Reiss TF
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):98-104. PubMed ID: 16892789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of montelukast and salmeterol on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction.
    Steinshamn S; Sandsund M; Sue-Chu M; Bjermer L
    Chest; 2004 Oct; 126(4):1154-60. PubMed ID: 15486377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
    Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
    Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge.
    Storms W; Chervinsky P; Ghannam AF; Bird S; Hustad CM; Edelman JM;
    Respir Med; 2004 Nov; 98(11):1051-62. PubMed ID: 15526805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening AP; Haahtela T; Holgate ST; Picado C; Menten J; Dass SB; Leff JA; Polos PG
    BMJ; 2003 Oct; 327(7420):891. PubMed ID: 14563743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group.
    Villaran C; O'Neill SJ; Helbling A; van Noord JA; Lee TH; Chuchalin AG; Langley SJ; Gunawardena KA; Suskovic S; Laurenzi M; Jasan J; Menten J; Leff JA
    J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):547-53. PubMed ID: 10482826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction.
    Kim JH; Lee SY; Kim HB; Kim BS; Shim JY; Hong TJ; Hong SJ
    Pediatr Pulmonol; 2005 Feb; 39(2):162-6. PubMed ID: 15633203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast.
    Philip G; Villarán C; Pearlman DS; Loeys T; Dass SB; Reiss TF
    J Asthma; 2007 Apr; 44(3):213-7. PubMed ID: 17454341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise.
    Rundell KW; Spiering BA; Baumann JM; Evans TM
    Br J Sports Med; 2005 Apr; 39(4):232-6. PubMed ID: 15793094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchoprotective effects of single doses of salmeterol combined with montelukast in thermally induced bronchospasm.
    Coreno A; Skowronski M; West E; El-Ekiaby A; McFadden ER
    Chest; 2005 May; 127(5):1572-8. PubMed ID: 15888830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
    Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
    N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients.
    Dockhorn RJ; Baumgartner RA; Leff JA; Noonan M; Vandormael K; Stricker W; Weinland DE; Reiss TF
    Thorax; 2000 Apr; 55(4):260-5. PubMed ID: 10722763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.
    Dempsey OJ; Wilson AM; Sims EJ; Mistry C; Lipworth BJ
    Chest; 2000 Apr; 117(4):950-3. PubMed ID: 10767223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval.
    Bronsky EA; Kemp JP; Zhang J; Guerreiro D; Reiss TF
    Clin Pharmacol Ther; 1997 Nov; 62(5):556-61. PubMed ID: 9390112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.